loadpatents
name:-0.035594940185547
name:-0.026997089385986
name:-0.038388013839722
Larsen; Scott D. Patent Filings

Larsen; Scott D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Larsen; Scott D..The latest application filed is for "glucosylceramide synthase inhibitors and therapeutic methods using the same".

Company Profile
6.26.37
  • Larsen; Scott D. - South Lyon MI
  • Larsen; Scott D. - Ann Arbor MI US
  • Larsen; Scott D. - Kalamazoo MI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Glucosylceramide synthase inhibitors and therapeutic methods using the same
Grant 11,220,479 - Larsen , et al. January 11, 2
2022-01-11
Glucosylceramide Synthase Inhibitors And Therapeutic Methods Using The Same
App 20210122712 - Larsen; Scott D. ;   et al.
2021-04-29
Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of the same
Grant 10,851,072 - Larsen , et al. December 1, 2
2020-12-01
Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same
Grant 10,662,183 - Larsen , et al.
2020-05-26
Inhibitors Of Rho/mrtf/srf-mediated Gene Transcription And Methods For Use Of The Same
App 20190308947 - Larsen; Scott D. ;   et al.
2019-10-10
Small Molecule Inhibitors Of Aldh And Uses Thereof
App 20190255055 - Larsen; Scott D. ;   et al.
2019-08-22
G protein-coupled receptor kinase inhibitors and methods for use of the same
Grant 10,329,283 - Larsen , et al.
2019-06-25
Glucosylceramide synthase inhibitors and therapeutic methods using the same
Grant 10,202,340 - Larsen , et al. Feb
2019-02-12
G protein-coupled receptor kinase 2 inhibitors and methods for use of the same
Grant 10,023,564 - Larsen , et al. July 17, 2
2018-07-17
G Protein-coupled Receptor Kinase Inhibitors And Methods For Use Of The Same
App 20180186779 - Larsen; Scott D. ;   et al.
2018-07-05
Glucosylceramide Synthase Inhibitors And Therapeutic Methods Using The Same
App 20180022697 - Larsen; Scott D. ;   et al.
2018-01-25
G Protein-coupled Receptor Kinase 2 Inhibitors And Methods For Use Of The Same
App 20170240538 - Larsen; Scott D. ;   et al.
2017-08-24
Therapeutic compounds and methods
Grant 9,598,441 - Rishi , et al. March 21, 2
2017-03-21
PPAR-sparing compounds for the treatment of metabolic diseases
Grant 9,562,012 - Tanis , et al. February 7, 2
2017-02-07
Methods and compositions for treating bacterial infection
Grant 9,504,688 - Ginsburg , et al. November 29, 2
2016-11-29
Methods and compositions for targeting cancer stem cells
Grant 9,468,632 - Buckanovich , et al. October 18, 2
2016-10-18
Ppar-sparing Compounds For The Treatment Of Metabolic Diseases
App 20160152570 - Tanis; Steven P. ;   et al.
2016-06-02
Inhibitors Of Myocardin-related Transcription Factor And Serum Response Factor (mrtf/srf)-mediated Gene Transcription And Methods For Use Of The Same
App 20160145251 - Larsen; Scott D. ;   et al.
2016-05-26
Methods And Compositions For Targeting Cancer Stem Cells
App 20150297577 - Buckanovich; Ronald ;   et al.
2015-10-22
Methods And Compositions For Inhibiting Rho/mrtf-mediated Diseases And Conditions
App 20150250769 - Larsen; Scott D. ;   et al.
2015-09-10
PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases
Grant 9,126,959 - Colca , et al. September 8, 2
2015-09-08
Methods And Compositions For Treating Bacterial Infection
App 20150132352 - Sun; Hongmin ;   et al.
2015-05-14
Ppar-sparing Thiazolidinedione Salts For The Treatment Of Metabolic Diseases
App 20150051406 - Colca; Gerard R. ;   et al.
2015-02-19
Synthesis for thiazolidinedione compounds
Grant 8,946,435 - Tanis , et al. February 3, 2
2015-02-03
Synthesis for thiazolidinedione compounds
Grant 8,937,182 - Zeller , et al. January 20, 2
2015-01-20
Synthesis for Thiazolidinedione Compounds
App 20140378687 - Tanis; Steven P. ;   et al.
2014-12-25
PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases
Grant 8,912,335 - Colca , et al. December 16, 2
2014-12-16
Synthesis for thiazolidinedione compounds
Grant 8,895,748 - Tanis , et al. November 25, 2
2014-11-25
Therapeutic Compounds And Methods
App 20140221412 - Rishi; Arun K. ;   et al.
2014-08-07
Novel Synthesis For Thiazolidinedione Compounds
App 20140018542 - Parker; Timothy ;   et al.
2014-01-16
Synthesis For Thiazolidinedione Compounds
App 20130211092 - Tanis; Steven P. ;   et al.
2013-08-15
Novel Synthesis For Thiazolidinedione Compounds
App 20130211095 - Parker; Timothy ;   et al.
2013-08-15
Novel Synthesis For Thiazolidinedione Compounds
App 20130204004 - Zeller; James R. ;   et al.
2013-08-08
Ppar-sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases
App 20130053350 - Colca; Gerard R. ;   et al.
2013-02-28
Ppar-sparing Thiazolidinediones And Combinations For The Treatment Of Diabetes Mellitus And Other Metabolic Diseases
App 20120322728 - Colca; Gerard R. ;   et al.
2012-12-20
Ppar-sparing Thiazolidinediones And Combinations For The Treatment Of Obesity And Other Metabolic Diseases
App 20120316138 - Colca; Gerard R. ;   et al.
2012-12-13
Ppar-sparing Thiazolidinedione Salts For The Treatment Of Metabolic Diseases
App 20120309975 - Colca; Gerard R. ;   et al.
2012-12-06
Antiviral agents
Grant 6,861,438 - Larsen , et al. March 1, 2
2005-03-01
Antiviral compounds
Grant 6,852,731 - Larsen , et al. February 8, 2
2005-02-08
Antiviral Compounds
App 20040242884 - Larsen, Scott D. ;   et al.
2004-12-02
Heterocycle carboxamides as antiviral agents
App 20040180910 - Schnute, Mark E. ;   et al.
2004-09-16
Heterocycle carboxamides as antiviral agents
App 20040142928 - Bundy, Gordon L. ;   et al.
2004-07-22
Antiviral agents
App 20040138449 - Larsen, Scott D. ;   et al.
2004-07-15
Heterocycle carboxamides as antiviral agents
App 20030207880 - Bundy, Gordon L. ;   et al.
2003-11-06
4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
Grant 6,624,160 - Vaillancourt , et al. September 23, 2
2003-09-23
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
App 20020082448 - Larsen, Scott D. ;   et al.
2002-06-27
Inhibitors of protein tyrosine phosphatase
Grant 6,410,585 - Larsen , et al. June 25, 2
2002-06-25
4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
App 20020045619 - Vaillancourt, Valerie A. ;   et al.
2002-04-18
4-hydroxycinnoline-3-carboxyamides as antiviral agents
App 20020042397 - Vaillancourt, Valerie A. ;   et al.
2002-04-11
Heterocycle carboxamides as antiviral agents
App 20020025960 - Bundy, Gordon L. ;   et al.
2002-02-28
Heterocycle carboxamides as antiviral agents
App 20020019397 - Schnute, Mark E. ;   et al.
2002-02-14
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
Grant 5,994,577 - Larsen , et al. November 30, 1
1999-11-30
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
Grant 5,955,617 - Larsen , et al. September 21, 1
1999-09-21
Pyridino substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents
Grant 5,565,468 - Larsen , et al. October 15, 1
1996-10-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed